COVID-MDR patients (n=12) at baseline
Age (years mean ±SD) 55±7
Sex male, n 10
Ethnical origin
Caucasian n=10 Asian n=1 African n=1
Intensive care characteristics
SOFA score = 4 Mechanical ventilation n=10 ARDS n=11 ECMO n=5 Hemodialysis n=6
Type of skin lesions Maculopapular n=11
Affected body surface area (%) 69 (51-80)
Time between COVID-19 diagnosis and MDR onset (days, median (range)) 25 (14-42)
Time between drug exposure and MDR onset (days, median (range)) 7 (5-30)
Length of skin lesions to resolution (days, median (range)) 13 (6-18)
Treatment of MDR
Topical steroids n=7 Systemic steroids n=4
MDR patients (n=7) at baseline MDR patients (n=7) at baseline
Age (years mean ±SD) 52±12
Sex male, n 5
Type of skin lesions maculopapular
Affected body surface area (%) 65 (60-80)
DRESS patients (n=5) at baseline DRESS patients (n=5) at baseline
Age (years mean ±SD) 47±8
Sex male, n 4
Type of skin lesions maculopapular
Affected body surface area (%) 74 (66-80)
Regiscar DRESS score (range) 6 (6-7)